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BackgroundK2P channels play a key role in stabilizing the restingmembranepotential, therebymodulating cell excitability in the central
andperipheral somaticnervous system.Whole-cell experiments revealeda riluzole-activated current (IRIL), transportedbypotassium, in
mouse superior cervical ganglion (mSCG) neurons. The activation of this current by riluzole, linoleic acid, membrane stretch, and
internal acidification, its open rectificationand insensitivity tomost classic potassiumchannel blockers, indicated that IRIL flows through
channels of the TREK [two-pore domain weak inwardly rectifying K channel (TWIK)-related K channel] subfamily. Whole-ganglia and
single-cell reverse transcription-PCR demonstrated the presence of TREK-1, TREK-2, and TRAAK (TWIK-related arachidonic acid-
activatedK channel)mRNA, and the expressionof these three proteinswas confirmedby immunocytochemistry inmSCGneurons. IRIL
was enhanced by zinc, inhibited by barium and fluoxetine, but unaffected by quinine and ruthenium red, strongly suggesting that it was
carried through TREK-1/2 channels. Consistently, a channel with properties identical with the heterologously expressed TREK-2 was
recorded in most (75%) cell-attached patches. These results provide the first evidence for the expression of K2P channels in the mam-
malian autonomic nervous system, and they extend the impact of these channels to the entire nervous system.
Introduction
Mammalian two-pore domain potassium channels (K2P) are en-
coded by 15 known genes (KCNK), and they are distributed into six
subfamilies [two-poredomainweak inwardly rectifyingK channel
(TWIK), TWIK-related K channel (TREK), TWIK-related acid-
sensitive K channel (TASK), TWIK-related alkaline-activated K
channel (TALK), TWIK-related halothane-inhibited K channel
(THIK), and TWIK-related spinal cord K channel (TRESK)].
Since their discovery (Lesage et al., 1996), the biophysical, pharma-
cological, andputative functional properties of cloned andheterolo-
gously expressedmammalianK2P channels have beenmethodically
investigated. Such an effort strongly contrasts with the scarce data
available from native K2P channels naturally expressed inmamma-
lian cells (for review, see Lotshaw, 2007). Among these K2P chan-
nels, the TREK subfamily [TREK-1, TREK-2, and TWIK-related
arachidonic acid-activated K channel (TRAAK)] is considered to
provide a source of background potassium channels with very weak
voltage dependency and a low open probability. As such, they are
involved in themaintenance of themembrane resting potential and
excitability (Mathie andVeale, 2007). Their low basal activity can be
strongly increased by physical and chemical stimuli such as mem-
brane stretch (Maingret et al., 1999a; Bang et al., 2000), temperature
(Maingret et al., 2000a), general anesthetics (Lesage et al., 2000b), or
neuroprotectivedrugs (Finket al., 1998;Duprat et al., 2000;Lesageet
al., 2000b), suggesting a wide range of promising functions.
For considerable time, the ionic and molecular nature of the
currents that sustain the resting membrane potential in sympa-
thetic neurons from the superior cervical ganglion (SCG) has
been pursued. A rather unpredictable and complex mechanism
emerged (Lamas et al., 2002), whereby at least three voltage-
dependent currents contribute to the resting current: the potas-
sium M-current (Brown et al., 1982), the cationic h-current
(Lamas, 1998), and, more recently, a persistent sodium current
(Lamas et al., 2009). Because only a small percentage of all these
voltage-dependent channels are open at rest, they probably have
a powerful stabilizing rather than a strong settling effect on the
resting membrane potential. Experiments designed to remove
the contribution of the known voltage-dependent currents and
the Na–K pump revealed an apparently voltage-independent
“leakage” current that was transportedmainly by potassium (La-
mas et al., 2002). However, as in most cell types, the molecular
nature of this leakage current remains to be determined.
We characterized a potassium current activated by riluzole
(IRIL) that is insensitive to most classic blockers of voltage- and
calcium-dependent ion currents. The electrophysiological, phar-
macological, and molecular approach followed provides strong
evidence that this current flows through K2P potassium channels
of the TREK subfamily. Single-channel data demonstrated the
strong expression of TREK-2 channels and aweaker expression of
an unidentified TREK-like channel. We hypothesize that K2P
channels may, at least in part, be responsible for the leak potas-
sium current in sympathetic neurons and that they modulate
their excitability.
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Materials andMethods
Animal handling and all experimental procedures were approved by the
Spanish Higher Research Council and the University of Vigo Scientific
Committee and they conformed to Spanish and European guidelines for
the protection of experimental animals (RD1201/2005; 86/609/EEC).
Cell culture. The conditions for mouse SCG cell culture have been
described previously (Martínez-Pinna et al., 2002; Romero et al., 2004;
Lamas et al., 2009). Mice (20–60 d of age) were terminally anesthetized
with CO2 and immediately decapitated. The SCG were removed in cold
Leibowitz medium (L-15) under a binocular microscope, and after
cleaning, the ganglia were chopped and incubated in collagenase (2.5
mg/ml inHBSS) for 15min at 37°C. After washing, the ganglia were then
incubated for 30min in trypsin (1mg/ml inHanks). Finally, the neurons
weremechanically isolated, centrifuged, and plated in 35mmPetri dishes
previously coated with laminin (10 g/ml in EBSS). Neurons were cul-
tured for 1–2 d at 37°C and 5% CO2 in L-15 medium containing the
following: 24 mM NaHCO3, 10% fetal calf serum, 2 mM L-glutamine, 38
mM D-glucose, 100 UI/ml penicillin, 100 g/ml streptomycin, and 50
ng/ml nerve growth factor. For electrophysiological purposes, only neu-
rons devoid of processes were used (Romero et al., 2004).
Perforated-patch whole-cell recording. Electrophysiological recordings
were performed under continuous perfusion (10 ml/min) at room
temperature using an Axopatch 200B amplifier (Molecular Devices). For
current-clamp experiments, the “Iclamp-fast” mode (simulating bridge
mode) of the same amplifier was used (Magistretti et al., 1998). Two-step
fire-polished patch pipettes with a tip resistance of 2–4 M were used
and perforated patch obtained with freshly prepared amphotericin B (75
g/ml) resulted in series resistance20 M (Rae et al., 1991). Junction
potentials5 mV were not corrected (Neher, 1992).
The sampling frequency was 2 kHz for voltage-clamp (filtering at 0.5
kHz) and 10 kHz for current-clamp experiments (filtering at 5 kHz); for
very long-lasting recordings, data were sampled at 100 Hz (filtering at 50
Hz). Data were digitized through a Digidata 1440A using the pClamp10
software (Molecular Devices) and they were analyzed and plotted using
the same software and Origin 7.5 (OriginLab Corporation). Averages
represent mean SEM, and the statistical significance was assessed with
two-sample Student’s t tests.
The standard pipette solution contained the following (in mM): 90
K-acetate, 20KCl, 3MgCl2, 1CaCl2, 3 EGTA, and 40HEPES, adding20
NaOH to a pH of 7.2. Standard bath solution contained the following (in
mM): 140 NaCl, 3 KCl, 1 MgCl2, 2 CaCl2, 10 D-glucose, and 10 HEPES,
adjusted to pH 7.2 with Tris [tris(hydroxymethyl)aminomethane]. To
induce intracellular acidosis, we substituted 90 mM NaCl with 90 mM
NaHCO3; changes in osmolarity were compensated for by adding su-
crose. For the high-potassium bath solution, we modified the standard
solution using 20mMKCl and 120mMNaCl. For symmetrical potassium
bath solution, we used 110 mM KCl and 30 mM NaCl. To obtain a me-
chanical stimulus, we switched the neurons from a 290 to a 145 mOsm
bath solution; both were standard solutions containing only 70mMNaCl
and their osmolarity was adjusted usingmannitol. The blockers added to
bath solutions included the following: 15 mM tetraethylammonium
(TEA), 2 mM 4-AP, 1 mM CsCl, 100 M CdCl, and 0.5 M TTX to block
voltage-dependent potassium, cationic, calcium, and sodium currents.
All solutions used were kept between 290 and 300 mOsm saving the
hypotonic solution.
Single-channel recording. Single-channel currents were recorded using
the cell-attached configuration and electrodes of 6 M. Acquisition
was set at 20 kHz and filtered at 2 kHz using the amplifier built-in filter.
Threshold detection for single-channel openings was set at 50% of the
maximum amplitude and patches containing more than one opening
level were discarded. Single-channel mean amplitude was measured us-
ing Clampfit 10 software and openings faster than 50 s were discarded.
Pipette and bath solutions contained the following (in mM): 150 KCl, 1
MgCl2, 5 EGTA, and 10 HEPES, buffered to pH 7.2 using KOH. Open
probability was calculated using the Clampfit software according to the
following equation: Po to/T, where to was the total time that the chan-
nel was found in the open state, and T is the total observation time.
Reverse transcriptase-PCR. Total RNA was isolated from the mouse
SCG and cerebral cortex samples using the RNeasy kit (QIAGEN) and
the Trizol method, respectively, and the purified RNA was stored at
30°C. The quality of the total RNA was assessed through its A260/A280
absorbance ratio, and it was verified by amplification of the constitutive
-actin gene by reverse transcriptase (RT)-PCR. Reverse transcription
from total RNA was performed using Moloney murine leukemia virus
(M-MLV) reverse transcriptase (Invitrogen), and each reverse transcrip-
tion reaction (30l) contained the following: 2g of total RNA, 3 ng/l
randomprimers (0.57 ng; Invitrogen), 6l of 2.5mM dNTPmix, RNase-
free water, 6l of 5 buffer (Invitrogen), 10U of RNaseOUT recombinant
ribonuclease inhibitor (Invitrogen), and200UofM-MLV(Invitrogen).The
reactions were performed at 37°C for 60 min, followed by 42°C for 15 min
and 95°C for 5min.
First-strand cDNA from all channels was PCR amplified with the spe-
cific primers described in Table 1 (Kang et al., 2004; Kang and Kim,
2006). Primers to amplify the constitutively active -actin gene were
designed using the program Primer Premier (Premier Biosoft Interna-
tional). Primer specificity was checked in the complete genome of Mus
musculus using the basic local alignment search tool (BLAST) program
(Altschul et al., 1990). The primers to amplify a 100 bp fragment of
TREK-1 were designed with the PRIMER-BLAST primer designing
tool. This program used Primer3 (Rozen and Skaletsky, 2000) to
design the PCR primers and then it submitted them to BLAST to
search against NCBI Transcript Reference Sequences of the genome of
M. musculus.
Amplifications were performed in a Mastercycler gradient thermocy-
cler (Eppendorf) as follows: 95°C for 5min; and then 35 cycles at 95°C for
45 s, specific T for 1 min, 72°C for 2 min; and a final extension step at
72°C for 15 min. The PCR amplification mixture (50 l) contained the
following: 50 ng of DNA template, 10 pmol of each primer, 0.2 mM
Table 1. Specific pair of primers used to amplify K2P channels and-actin gene
Name Nucleotide sequence (5	–3	) T a (°C) bp Reference
-Actin ActineF F: TGCCGCATCCTCTTCCTC 53 655 This study
ActineR R: CGCCTTCACCGTTCCAGT This study
TREK-1 TREK1F F: CTTTGGCTTTCTACTGGCTG 55 678 This study
R: GACCGTTCAGATAGATGCTC Kang and Kim, 2006
TREK-2 F: GGCTAATGTCACTGCTGAGTTCC 55 625 Kang and Kim, 2006
R: ACAAGACAACACATAGTCCAATTCC Kang et al., 2004
TRAAK F: CACCACTGTAGGCTTTGGCGATTATG 55 448 Kang and Kim, 2006
R: ACTCTGCGTGTCTGAGGACTCGTCG Kang and Kim, 2006
TREK-1 TREK1scF F: TCACTCTGACGACCATTGGA 54 100 This study
TREK1scR R: ACGAGGATCCAGAACCACAC This study
F, Forward; R, reverse; Ta, annealing temperature.
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dNTPs, 1.5mMMgCl2, 1.25U ofTaqDNApolymerase (Invitrogen), and
5 l of 10 reaction buffer (Invitrogen). PCR products were cleaned
before cloning using the Wizard SV Gel and the PCR Clean-Up System
(Promega) according to the manufacturer’s protocol.
Cerebral cortex tissue was used as a positive control for the PCR am-
plification of the channels, and -actin expression was assessed to check
the quality of the RNA.Negative controls were also performed to exclude
contamination (Fig. 5A, lanes not labeled). The RT-PCR products am-
plified corresponding to the partial TREK-1, TREK-2, and TRAAK PCR
amplicons were cloned into the vector pGEM-T (Promega) using the
pGEM-T Vector System II (Promega) with JM109 competent cells and
sequenced on both strands with the dideoxynucleotide chain termina-
tion method using T7 and SP6 primers.
Single-cell PCR. Single-cell RT-PCR was performed using QIAGEN
OneStep RT-PCR kit (QIAGEN) with specific primers for TREK-1
(TREK1scF and TREK1scR), TREK-2, and TRAAK, respectively (Table
1). As a positive control, primers for -actin were also used to detect
mRNA expression. Reverse transcription was performed at 50°C for 30
min, and the PCR amplifications were then performed as follows: poly-
merase activation step at 95°C for 15min; 35 cycles at 94°C for 45 s, 54°C
for 1 min, 72°C for 2 min; and a final extension step at 72°C for 10 min.
The RT-PCR amplification mixture (50 l) contained 20 l of DEPC
water with the cytoplasm from a single neuron or a complete cell, 10
pmol of each primer, 0.4 mM of each dNTP, 2 l of QIAGEN OneStep
RT-PCREnzymeMix and 10l of 5QIAGENOneStepRT-PCRBuffer
with 12.5 mM MgCl2. PCR products were visualized on 2% agarose gels
with ethidium bromide.
Immunocytochemistry. Cultured cells were fixed with paraformalde-
hyde (2%; for 1 h) at room temperature and then washed with PBS
(Sigma-Aldrich) with gentle shaking. Permeabilization was performed
by bathing the cells in PBS containing Triton X-100 (0.2%; Sigma-
Aldrich) for 10min and thenwashed out with PBS.Nonspecific antibody
binding was blocked by incubating the cells in normal donkey serum
(NDS) (10%) in PBS for 30 min at room temperature. The dishes were
incubated overnight at 4°C with the primary antibodies against TREK-1,
TREK-2, or TRAAK (sc-11556, sc-11560, sc-
11326) diluted 1:100. After incubation, cells were
rinsed in PBS (three times for 5 min each time),
followed by incubation with FITC-conjugated
anti-goat secondary antibody (1:200) for 1 h at
room temperature; finally, they were washed
withPBS(three times for5mineach time).At the
end of the procedure, the nuclei were stained
with 4	,6	-diamidino-2-phenylindole (DAPI) (1:
10,000dilution for2min;SantaCruzBiotechnol-
ogy) and mounted (ProLong Gold; Invitrogen).
Negative controls were obtained, treating cul-
turedneurons identicallywithout adding the pri-
mary antibody, and no neuronal labeling was
observed. The same antibodies against TREK-1
and TREK-2 were carefully tested by Deng et al.
(2009), and all of them have been successfully
used in trigeminal ganglion cells recently
(Yamamotoet al., 2009).All antibodieswerepur-
chased from Santa Cruz Biotechnology, and all
antibody solutions were prepared in 2% NDS in
PBS. Images were acquired with a confocal Leica
SP5 microscope using LAS AF 2.0 software. The
wavelengths used were 488/493–581 nm for
FITC and 405/415–526 nm for DAPI.
Results
Long-lasting application of the neuropro-
tective agent riluzole (100 M; 5 min) to
cultured mouse SCG (mSCG) neurons
clamped at 30 mV invariably induced
an outward current (89.6 4.8 pA; n 6;
peak current) in standard solutions (Fig.
1A, top trace). Conversely, the same ap-
plication induced a hyperpolarization of11.2 2.2 mV (n 11;
peak voltage) in neurons manually fixed at 30 mV in current-
clamp experiments (Fig. 1B, top trace). When the application of
riluzole was sustained (5 min), both the outward current and the
hyperpolarization reached a peak after 107.6  7.6 s (n  6) and
105 19 s (n 11), respectively, which then declined (Fig. 1A,B,
top traces).A similar transient effect of riluzolehasbeen reported for
heterologously expressedTREK-1 (Duprat et al., 2000) andTREK-2
(Lesage et al., 2000b) homodimers. In these heterologously ex-
pressed channels, inhibition was observed after the initial phase of
direct current activation, which was attributed to a secondary in-
crease of cAMP by riluzole. By contrast, the activation of TRAAK,
the other member of the TREK subfamily, persisted in the presence
of riluzole (Duprat et al., 2000).
It is noteworthy that the effect of riluzole (100M)was smaller
at more hyperpolarized membrane voltages, whereas at rest
(61.1  1.1 mV; n  5), a small hyperpolarization was only
observed in three of five cells tested (5.2 1.3 mV; n 3) (Fig.
1B, bottom trace). Similarly, under voltage-clamp conditions,
the riluzole-activated current was strongly reduced by clamping
themembrane at50 rather than30mV (25.3 8.1 pA; n 4;
p  0.05) (Fig. 1A, bottom trace). To obtain a more consistent
effect on the resting membrane potential, we increased the con-
centration of riluzole to 300 M. In voltage clamp and at 30
mV, this concentration of riluzole evoked a current of 188.3 
35.7 pA (n 8) (supplemental Fig. 1, available at www.jneurosci.
org as supplemental material) and it induced a hyperpolarization
of approximately8mV (from62.4 2.3 to70.6 2.3mV;
n 15; p 0.05) (data not shown) in all cells tested.
These initial results strongly suggested that IRIL was trans-
ported mainly through K2P TREK-1 and/or TREK-2 channels in
Figure 1. Riluzole activates an outward current in mSCG neurons. A, Application of riluzole induced a clear transient outward
current when the membrane was held at30 mV (top trace). The amplitude of IRIL was strongly reduced at more negative
membrane potentials (bottom trace). Short-duration hyperpolarizing voltage pulseswere continuously applied to follow changes
in conductance. B, In neurons manually current clamped at30 mV, riluzole application induced a clear membrane hyperpolar-
ization (top trace), an effect that was strongly reduced or absent at resting membrane potentials (bottom trace). C, The peak
amplitude of the riluzole-activated current was unaffected by blockers of voltage-dependent sodium channels (a), persistent
sodium channels (b), voltage-activated calcium channels (c), and hyperpolarization-activated cationic channels (d).
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SCG neurons, although the variability in
the current decline over long-term expo-
sure to riluzole prevented the involve-
ment of TRAAK from being discarded.
Ionic nature of the riluzole-activated
outward current
Riluzole inhibits voltage-activated so-
dium channels (Hebert et al., 1994; Re-
boreda et al., 2003; Wang et al., 2008), as
reflected by the inhibition of transient and
persistent sodium currents in cultured
mSCG neurons (Lamas et al., 2009). As
inhibition of a persistent sodium current
would induce an apparent outward cur-
rent, negative 15 mV voltage steps of 50
mswere applied at 0.4Hz to track the vari-
ations in conductance induced by ri-
luzole. Riluzole provoked an increase in
conductance of 1.4 nS (from 2.8 0.2 to
4.2  0.2 nS; n  5) (Fig. 1A, top trace),
suggesting that the outward current was at-
tributable to the opening of potassium
channels rather than to the blockage of so-
dium channels. Long applications of ri-
luzole (100 M for 5 min) were used to test
the effect of several blockers of nonpotas-
sium channels, using the current induced in
standard solutions at 30 mV (see above)
as a control.
Persistent sodium currents in SCG
neurons are sensitive to TTX and val-
proate (Lamas et al., 2009), yet at concen-
trations that strongly inhibit the sodium
current (0.5 and 100 M, respectively),
neither of these compounds induced an
outward current similar to that provoked
by riluzole at 30 mV (Fig. 1Ca,Cb). In-
deed, the amplitude of the riluzole-
activated outward current recorded in the
presence of TTX (97.8 18.1 pA; n 7)
or valproate (76.6  14.5 pA; n  4) was
not significantly different from that recorded in control condi-
tions ( p
 0.05) (see also Fig. 3E). Moreover, the hyperpolariza-
tion induced by long applications of riluzole in the presence of
valproate (16.4  1.2 mV; n  4) or TTX (13.5  2.6 mV;
n 4) in current-clamp experiments was no different from that
obtained in standard solutions ( p
 0.05; cellsmanually clamped
at 30 mV) (data not shown). Riluzole also inhibits voltage-
dependent calcium channels (Huang et al., 1997). However, cad-
mium (100 M) did not affect the current at 30 mV in mSCG
neurons, and the riluzole-activated current in the presence of cad-
mium was not significantly different from the control (94.8  8.7
pA; n  9) (Figs. 1Cc, 3E) ( p 
 0.05). The hyperpolarization-
activated cation current (Ih) fulfils an important role in stabilizing
the restingmembrane potential in SCGcells (Lamas, 1998; Lamas et
al., 2002; Romero et al., 2004). Nevertheless, the inhibition of this
current with 1 mM cesium did not affect the riluzole-activated cur-
rent (78.9 15.7 pA; n 4) (Figs. 1Cd, 3E) ( p
 0.05).
To further characterize the nature of the riluzole-activated
outward current, riluzole (100M; 30 s) was applied to cells fixed
at different membrane voltages, both in standard solutions ([K]o
 3mM; EK91mV) (Fig. 2A), as well as in a high-potassium
extracellular solution ([K]o 20 mM; EK43 mV) (Fig. 2B).
The current–voltage curve ( I–V) for IRIL in standard potassium
concentrations (Fig. 2C, dots) showed a strong outward recti-
fication that nearly vanished in 20 mM extracellular potassium
(Fig. 2C, squares). A similar outwardly rectifying I–V was ob-
tained when the riluzole-activated current was isolated using repet-
itive negatively progressing voltage ramps (100 mV/s, every 10 s)
(Fig. 2D). The current evokedby the rampat the peak of the riluzole
effect was subtracted from that obtained before riluzole was applied
to define the riluzole-activated current. The I–V strongly rectified in
standard but not at symmetrical potassium concentrations (EK 0
mV) (Fig. 2D); note that, in experiments using voltage ramps, TTX,
Cd2, and Cs were added to the extracellular solution. Similar
outwardly rectifying I–V relationships were obtained for currents
through heterologously expressed TREK-1 (Fink et al., 1996),
TREK-2 (Lesage et al., 2000b), and TRAAK (Fink et al., 1998) chan-
nels at physiological potassium concentrations.
In summary, riluzole activated an outward current with a re-
versal potential closely following the equilibrium potential for
potassium, and the contribution of sodium, calcium, and cat-
ionic channels to IRIL can be ruled out.
Figure 2. IRIL is a potassium current with a reversal potential that follows the Nernst equation. A, In physiological external
potassium concentrations (3 mM), short applications of riluzole evoked increasing outward currents at potentials more positive
than80 mV. In most cells tested, no inward currents could be obtained at more negative voltages. B, Inward currents were
obtained at potentials below to40 mV when the extracellular potassium concentration was elevated to 20 mM. C, Current–
voltage relationships for the riluzole-induced currents shown in A and B. Note that the marked outward rectification in 3 mM
potassium (dots) was strongly reduced in 20 mM potassium (squares). In both cases, the reversal potential of IRIL was close to the
Nernst equilibriumpotential for potassium.D, Current–voltage relationships for riluzole-induced currents obtained in response to
negatively progressing voltage ramps. The current obtained in the control was subtracted from that obtained in the
presence of riluzole (100M) (close to the peak). Note that the strong outward rectification obtained in standard solutions
(EK91 mV) disappeared when symmetrical concentrations of potassium were used (EK 0 mV). Recordings were
acquired from two different cells.
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Classic potassium channel blockers
K2P channels are in general insensitive to the external application
of classic potassium channel blockers like TEA, 4-AP, or Cs, but
they can be blocked by barium. Once the potassium nature of the
riluzole-activated current was demonstrated, we assessed the pu-
tative effect of riluzole on potassium channels other than K2P by
testing the effect of several known potassium channel blockers.
In standard solutions, the current evoked by the application of
riluzole (100M) in the presence of external TEA (15mM; 78.9
11.3 pA; n  5) (Fig. 3A) or 4-AP (2 mM; 79  13.2 pA; n  3)
(Fig. 3B) was not statistically different from the control current
( p 
 0.05). Although riluzole activates calcium-dependent BK
(Wang et al., 2008) and SK (Grunnet et al., 2001) potassium
channels, the current recorded at30mVwas not affected by the
coapplication of apamin (200 nM) and paxilline (1 M), and the
riluzole-activated current in the presence of these toxins was not
significantly different from control (106.5 15.7 pA; n 6; p

0.05) (Fig. 3C).
Among the potassium channel blockers tested, only barium (5
mM) affected the current evoked by riluzole, producing a strong
reduction (37  6.3 pA; 58.7%; n  4) (Fig. 3D) ( p  0.01). It
is noteworthy that barium inhibits heterologously expressed
TREK-1 (Fink et al., 1996), TREK-2 (Bang et al., 2000), and
TRAAK (Fink et al., 1998) channels. As shown in Figure 3, both
barium and TEA (but not other blockers) strongly inhibited
the steady-state outward current at 30 mV, such inhibition
representing the blockage of the non-inactivating potassium
M-current characteristic of SCG neurons (Hadley et al., 2003;
Romero et al., 2004).
When taken together, the results obtained using channel
blockers not only suggested that the riluzole-activated outward
current is attributable to themodulation ofK2P channels but also
they rule out the contribution of other voltage-gated and
calcium-dependent channels (Fig. 3E).
TREK channel modulators
There are no completely specific or selec-
tivemodulators distinguishing among the
different K2P channel subtypes (for re-
view, see Lotshaw, 2007), and therefore,
we tested several of the innumerable
pharmacological agents that interact
with them. While some enabled us to rule
out the participation of a given subfamily
or subtype with a degree of confidence,
others strongly indicated that the TREK
subfamily was the origin of the riluzole-
activated outward current. To avoid the
possible interactions of K2P modulators
with other currents, these experiments
were performed in a blockers solution (see
Materials and Methods) with extended
application of riluzole. In such condi-
tions, 100 M riluzole induced an out-
ward current of 84.4  14.2 pA (n  5;
peak current), and this value was consid-
ered as the control. Note that the outward
current obtained was not statistically differ-
ent fromthatobtained in standard solutions
( p 
 0.05). Moreover, a dose–response
curve for riluzole in the blockers solution
provided an EC50 of 139.4M (supplemen-
tal Fig. 1, available at www.jneurosci.org as
supplemental material).
Most K2P channels are inhibited (TASK-3, TRAAK, TWIK-2,
TRESK) or unaffected (THIK-1) by micromolar concentrations
of zinc; only heterologously expressed TREK-1 (Czirja´k and
Enyedi, 2006) and TREK-2 (Kim et al., 2005) are clearly activated
by this ion. TASK-1 and TASK-2 were reported to be slightly
inhibited (Reyes et al., 1998), unaffected (Clarke et al., 2004), or
slightly enhanced (Czirja´k andEnyedi, 2006) by zinc. Application
of zinc (100 M) to cells bathed in the blockers solution induced
a slowly developing outward current (46.3  12.3 pA; n  5;
measured after 4min application) and the riluzole-activated cur-
rent was enhanced (127.5 10.9 pA; n 6; p 0.05) (Fig. 4A).
Because expressed mouse TRAAK channels are inhibited by zinc
(Czirja´k and Enyedi, 2006), these results ruled out a major con-
tribution of TRAAK channels to IRIL. The antidepressant fluox-
etine strongly inhibits heterologously expressed TREK-1
channels at concentrations that do not affect TRAAK channels
(Kennard et al., 2005; Heurteaux et al., 2006); this drug seems to
also inhibit TREK-2 cannels (Kang et al., 2008). In mSCG neu-
rons fixed at 30 mV, fluoxetine (100 M) induced a clear in-
ward current (85.7 11.4 pA; n 9) and robustly reduced the
riluzole-activated current in blockers solutions (30.6  5.2 pA;
n  9, p  0.01) (Fig. 4B), again pointing to a weak, if any,
contribution of TRAAK channels to IRIL. The inward current
induced by fluoxetinemay be attributable to the inhibition of the
low K2P basal activity, but also to the inhibition of delayed recti-
fier channels, that could be not completely blocked by our block-
ers solution, as previously reported (Hahn et al., 1999; Yeung et
al., 1999). In general, quinine and quinidine are considered as
K2P blockers (Lotshaw, 2007; Mathie and Veale, 2007), and in
mSCG neurons, quinine (300 M) induced an inward current at
30 mV (77.5  10.6 pA; n  8) that we attributed to the
reduction of remaining M-current incompletely blocked by the
blockers solution. Indeed, M-current inhibition by quinine has
been reported in bullfrog sympathetic neurons (Imai et al., 1999)
Figure3. IRIL is transported throughK2P channels.A–C, The riluzole-induced currentwasnot affectedby thepresence of classic
potassium channel blockers TEA, 4-AP, apamine, and paxilline, indicating that IRIL is not transported through voltage- or calcium-
activated potassium currents.D, Barium clearly and significantly reduced the outward current evoked by riluzole. The scale bars in
this figure apply to all the panels. E, Bar diagram summarizing the main results obtained using ion channel blockers. This figure
represents themean SEM for the peak current induced by 100M riluzole at a holding potential of30mV. **p 0.01 versus
control.
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as well as in neuroblastoma cells (Robbins et al., 1992). Although
IRIL was slightly reduced in the presence of quinine (Fig. 4C), the
mean current was not different from that in the control (60 
13.2 pA; n 8; p
 0.05). TRAAK, but not TREK-1, homodimers
are highly sensitive (IC50 of 2 M) to the inhibition with ruthe-
nium red (RR) (Czirja´k and Enyedi, 2002), but application of 10
MRRwhen IRIL was totally activated did not affect the current in
mSCGneurons (supplemental Fig. 2, available at www.jneurosci.
org as supplemental material).
Strong activation of TREK-1 and TREK-2 by internal acidifi-
cation (Maingret et al., 1999b; Bang et al., 2000; Duprat et al.,
2000; Lesage et al., 2000b) is a characteristic that may be used to
distinguish thesemembers of the TREK subfamily from the other
K2P channels (Patel and Honore, 2001). As the other member of
this subfamily (TRAAK) is unaffected by internal acidification
(Fink et al., 1998; Maingret et al., 1999b), this property is also
useful to discriminate among members of this subfamily. We
used dinitrophenol (DNP) (300M) as ametabolic inhibitor that
decreases the intracellular ATP concentration and acidifies the
cytosol. Surprisingly, DNP induced a small inward current
(30.1 6.2 pA;n 7) (data not shown) inmSCGcells clamped
at 30 mV and the riluzole-evoked current in the presence of
DNP was not statistically different from the control (80  16.6
pA; n 7; p
 0.05). However, internal acidification by external
application of bicarbonate (Maingret et al., 1999b) induced a
strong outward current (213.8  22.6 pA; n  6) that was ro-
bustly inhibited by fluoxetine (100M) (Fig. 4D), as expected for
a current carried by TREK-1 and/or TREK-2 channels.
All members of the TREK subfamily are activated by unsatur-
ated fatty acids (Fink et al., 1998; Patel et al., 1998; Bang et al.,
2000). In mSCG neurons, application of linoleic acid (10 M)
induced a consistent and very slowly de-
veloping outward current (Danthi et al.,
2003), reaching 171.5  14.3 pA after 10
min application (n  4). The current in-
duced by linoleic acid was also strongly
inhibited by fluoxetine (supplemental Fig.
3A, available at www.jneurosci.org as sup-
plemental material). Membrane stretch is
also known to activate TREK channels
andTRAAKhas been reported to bemuch
lessmechanosensitive thanTREK-1 (Patel
et al., 1998; Maingret et al., 1999a,b; Bang
et al., 2000). The modification of the ex-
tracellular osmolarity from 290 to 145
mOsm induced an obvious cell swelling
and evoked a fast and clear outward cur-
rent (122.7  22.2 pA; n  4) in mSCG
neurons fixed at 30 mV. This stretch-
activated current was also very sensitive to
fluoxetine in the presence of the blockers
(supplemental Fig. 3B, available at www.
jneurosci.org as supplemental material).
In summary, experiments using K2P
modulators indicate that TRAAK chan-
nels do not contribute substantially to IRIL
(Fig. 4E).
Expression of mRNA for TREK
subfamily K2P channels
The mRNA for K2P channels is widely
distributed through the CNS (Talley et al.,
2001). TREK-1 was the first K2P channel
to be confirmed in the nervous system of mammals, and it is
highly expressed in themouse and humanbrain (Fink et al., 1996;
Lesage et al., 2000b). Also TREK-2 (Bang et al., 2000; Lesage et al.,
2000b) and TRAAK (Fink et al., 1998; Lesage et al., 2000b) are
strongly expressed in brain. However, the expression of mRNA
for TREK channels (or even for K2P channels) in the autonomic
nervous system has yet to be reported. Since the combination of
electrophysiology with pharmacology did not unequivocally de-
fine whether IRIL was transported through TREK-1, TREK-2, or
both, we studied the expression of their mRNA.
We first assessed the expression of mRNA for the three mem-
bers of the TREK subfamily by RT-PCR and found TREK-1,
TREK-2, and TRAAK mRNA in the entire ganglion (Fig. 5A).
Although ganglia are relatively homogeneous structures, the pos-
sibility of contamination with non-neuronal cells could not be
discarded. To circumvent this problem, single-cell RT-PCR was
performed using previously identified cultured neurons. Also, in
these circumstances, expression of mRNA for the three TREK
members was detected (Fig. 5B). Interestingly, in these studies,
the signal for TRAAK was always fainter than that of the other
two.
Immunocytochemistry for TREK subfamily K2P channels in
mouse SCG neurons
Having found mRNA for the three members of the TREK sub-
family in mSCG neurons, we tested whether they were all trans-
lated into proteins since complete agreement between protein
and mRNA localization is not always found for K2P channels
(Talley et al., 2001). Nevertheless, the expression of the TREK-1
(Maingret et al., 2000b), TREK-2 (Li et al., 2005), and TRAAK
Figure 4. TREK but not TRAAK channels provide themain contribution to IRIL. A, Application of zinc tomSCG neurons induced a
slowly developing outward current and significantly increased the riluzole-activated current. B, Fluoxetine induced an inward
current at30mV and strongly reduced IRIL. C, Quinine also provoked an inward current, but the effect on the riluzole-activated
current was not statistically significant. D, Internal acidification by extracellular bicarbonate resulted in the activation of an
outward current that was completely blocked by fluoxetine. E, Peak amplitude of riluzole activated currents in the presence of
modulators of TREK channels. *p 0.05 and **p 0.01 versus control. All the experiments in this figure were carried in the
blockers extracellular solution, and the membrane was held at30 mV. The scale bars in A apply for B and C.
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(Reyes et al., 2000) proteins was reasonably consistent with the
data obtained by in situ hybridization and RT-PCR.
We investigated the immunolocalization of the three mem-
bers of the TREK family in culturedmSCGcells. In these cultures,
neurons can be readily identified and FITC immunoreactivity
(green) was observed for all the three TREK-1, TREK-2, and
TRAAK channels in mSCG neurons but not in satellite cells (Fig.
6A–C, panels on the right show bright-field images of the same
field to clarify cell morphology). In culture, mSCG neurons are
often surrounded by one or two satellite cells having amore dense
nucleus when labeled with DAPI (blue), but these were never
associated with FITC fluorescence.
Single-channel recording
TREK channels have unique single-channel properties that have
been used to distinguish among them (Han et al., 2003; Kang and
Kim, 2006), and thus, we obtained cell-attached recordings at
symmetrical concentrations of potassium (150 mM KCl) to iden-
tify which of these channels are functionally expressed in the
membrane of mSCG neurons. In 16 of 32 cell-attached patches
from mSCG neurons, we detected TREK-like channel activity,
both at rest and well beyond the resting membrane potential (up
to 100 mV). In 12 of these 16 patches (75%), a potassium
channel was recorded with properties nearly identical with those
reported for TREK-2 (Han et al., 2003; Kang et al., 2006). Accord-
ingly, the single-channel conductance was 128.2 6.9 pS at60
mV and 53.8  2.3 pS at 60 mV (Fig. 7Aa) (n  12), and the
mean current–voltage relationship showed a characteristic in-
ward rectification (Fig. 7Ab) (n 12). By contrast, in 3 of the 16
patches (18.7%), displaying activity at negative potentials, we
detected a different channel (Fig. 7Ba) with milder inward recti-
fication (Fig. 7Bb) and a single-channel conductance of 70.1 
2.3 and 57.1  4.1 pS at 60 and 60 mV, respectively. These
values do not match any heterologously expressed channel of the
TREK subfamily reported previously, although they are very
close to those reported for a novel TREK-like channel found in
native magnocellular neurosecretory cells
isolated from the supraoptic nucleus
(Han et al., 2003).
In a second group of experiments, we
included riluzole (300 M) or riluzole
(300 M) plus fluoxetine (100 M) in the
recording electrode; in this group, we
found TREK-2 activity in 12 of the 31
patches tested. The solution at the tip of
the electrode was free of drugs to provide
enough time to obtain a good cell-
attached seal before the drugs reached the
membrane. Once the gigaseal was ob-
tained (time 0), the open probability was
measured every 5 min by analyzing trace
fragments of 2 s. The channel open prob-
ability progressively increased (from
0.02 0.01 to 0.6 0.05, n 6; 5 and 25
min after patching, respectively) (supple-
mental Fig. 4A,C, available at www.
jneurosci.org as supplemental material)
when using pipettes containing riluzole.
The increase in activity was almost negli-
gible when fluoxetine was also included
into the electrode (from 0.06  0.05 to
0.12  0.09; n  6) (supplemental Fig.
4B,C, available at www.jneurosci.org as
supplemental material). The difference between both treatments
was statistically significant 15 min after the seal was obtained
( p 0.05) and was nearly maximum after 20 min ( p 0.01).
As expected from the pharmacological and single-cell PCR
data, channels with properties similar to those reported for
TRAAK homodimers were not found. Surprisingly, linear I–V
relationships like those reported for heterologously expressed
TREK-1 channels (Han et al., 2003; Kang et al., 2006) were also
absent in mSCG neurons. These experiments indicated that
TREK-2 andTREK-like channels are active at rest, andhence they
must contribute to the resting membrane conductance in mSCG
neurons.
Resting membrane potential and firing
To further investigate the importance of TREK channels in the
behavior of mSCG neurons, we tested the effect of the blocker
fluoxetine on the restingmembrane potential. Several concentra-
tions of fluoxetine (1, 3, 10, 30, and 100 M) were applied to
resting neurons (I  0) and found a consistent depolarization
when using 100 M (12 mV; from61.1 3.9 to48.7 5.3
mV; n  3; p  0.015). The depolarization induced by lower
concentrations of fluoxetine on the resting potential was not sig-
nificant (30M: p 0.06, n 3; 10M: p 0.1, n 6; 3M: p
0.24, n 3; 1 M: p 0.51, n 3).
In initial experiments, we tested the effect of fluoxetine (1, 3,
10, and 30 M) on the amplitude and duration of the action
potentials evoked by 1 s depolarizing current injections (from 50
to 350 pA in 50 pA steps). Concentrations 
10 M clearly de-
creased the amplitude and increased the duration of action po-
tentials by inhibition of the voltage-activated sodium current
(Hahn et al., 1999). For this reason, we tested the effect of low
concentrations of fluoxetine on the number of action potentials
generated by current injections. A characteristic typical of SCG
neurons is their strong spike frequency adaptation when depo-
larized (Romero et al., 2004); however, neither 1 nor 10 M flu-
oxetine significantly affected the adaptation of mSCG neurons in
Figure 5. mSCG neurons expressmRNAs encoding all themembers of the TREK subfamily.A, Expression ofmRNAs for the TREK
channels in thewholemSCG and cerebral cortex as assessed by RT-PCR using specific primers for each K2P channel. DNA fragments
were cloned and sequenced for confirmation. The expected band sizeswere 678 bp (TREK-1, lanes 2, 3, 4, 5), 625 bp (TREK-2, lanes
7, 8, 9, 10), 448bp (TRAAK, lanes 12, 13, 14, 15), and655bp (-actin, lanes 17, 18). The first lane shows the100bp ladder (Takara).
Negative controls are shown in lanes 6, 11, 16, and 19.B, Expression of TREK-1 (left), TREK-2 (middle), and TRAAK (right)mRNA in
individual mSCG cells assessed by single-cell RT-PCR.
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terms of the number of action potentials (n 7) (supplemental
Fig. 5B, available at www.jneurosci.org as supplemental mate-
rial). Notwithstanding, a closer inspection of these seven neurons
showed that 10M fluoxetine significantly reduced the latency to
the first evoked action potential (from 21.6  4.8 to 18.8  4.6
ms; n 7; p 0.05; injected current, 150 pA); in the same cells,
the effect of 1 M was not significant (21.4  4.8 ms; p 
 0.05)
(supplemental Fig. 5A, available at www.jneurosci.org as supple-
mental material).
Discussion
The restingmembrane potential of SCGneurons lies around60
mV and it is contributed to by several voltage-gated currents and
the electrogenicity of the Na–K pump. However, as in many
other cell types, a molecularly unidentified apparently
voltage-independent (leak) conductance, which is mainly
transported by potassium, was proposed to be the main con-
tributor to the background current in such neurons. Here, we
have studied a riluzole-activated potassium current carried by
the recently discovered K2P channels that may be the molec-
ular basis of the resting leakage current in SCG neurons. In-
deed, we provide electrophysiological, pharmacological,
molecular, and immunocytochemical data demonstrating that
the TREK subfamily of the K2P potassium channels is the
molecular correlate of the riluzole-activated current. In addi-
tion, for the first time, we demonstrate the functional expres-
sion of K2P channels in the autonomic nervous system.
A characteristic of K2P channels is their modulation by many
pharmacological agents, but, despite considerable effort, selective
and specific modulators are still lacking even for heterologously
expressed channels. Accordingly, the few studies on putatively
native K2P channels have used multichemical screening to rule
out the contribution of other channels and to indirectly define
the channel responsible (Talley et al., 2000; Bushell et al., 2002;
Enyeart et al., 2002; Han et al., 2002). Single-channel recording
has also been combinedwith pharmacological screening in native
neurons (Han et al., 2002, 2003; Kang and Kim, 2006), and using
this approach, we show here that the riluzole-activated current is
mainly transported through TREK-2 channels in sympathetic
neurons.
Nature of the riluzole-activated current in mSCG neurons
The reversal potential of IRIL at different potassium concentra-
tions demonstrated that it is indeed a potassium current, and
accordingly, this current was unaffected by sodium, calcium, and
cationic channel modulators. Additional evidence indicated that
IRIL depends on K2P but not other known potassium channels.
Open rectification at physiological but not symmetrical potas-
sium concentrations is a characteristic of several K2P chan-
nels, ruling out the participation of voltage-dependent
potassium channels. Certainly, IRIL was insensitive to classic
voltage-dependent and calcium-activated potassium channel
blockers, although the current was reduced by millimolar con-
centrations of barium, a characteristic shared by several K2P
potassium channels.
To ascertain which type of K2P channel is responsible for the
IRIL was muchmore complicated. The activation by riluzole itself
pointed to the TREK subfamily since, to our knowledge, this is
the only K2P subfamily reported to be clearly activated by this
neuroprotective agent. Even though a putative THIK-1 channel
naturally expressed by mouse Purkinje neurons is inhibited (but
not activated) by riluzole (Bushell et al., 2002). Open rectification
and inhibition by barium and not by other classic channel block-
ers also support this notion. In addition, either application of
linoleic acid or mechanical stimulation induced clear outward
currents in blockers solutions. Finally, RT-PCR, single-cell RT-
PCR, and immunocytochemical data confirmed the expression
of mRNA and protein for the three members of the TREK sub-
family in mSCG neurons.
Molecular counterpart of IRIL
The coexpression of several different K2P subunits in the same
native neuron seems to be the norm (Han et al., 2003; Kang and
Kim, 2006). Accordingly, PCR and immunocytochemistry ex-
periments indicated that the threemembers of theTREK subfam-
ily are expressed in mSCG neurons (TREK-1, TREK-2, and
TRAAK). As all of them are activated by riluzole in heterologous
systems, we attempted to elucidate the relative contribution of
each of them to IRIL in our preparation.
We found enough pharmacological evidence to demonstrate
that TRAAK channels, although expressed, are not important
contributors to the current activated by riluzole in mSCG neu-
rons. Although varying from cell to cell, the activation of the
current by riluzole was transient in most cells tested, as reported
for heterologously expressed TREK-1 and TREK-2 channels.
This was contrary to the sustained activation reported for
TRAAK channels in the same conditions.
Among the 12 functional K2P subunits known, only TREK-1
and TREK-2 channels are activated by zinc, whereas most K2P
channels, including TRAAK, are inhibited (TASK-3, TASK-2,
TRAAK, TWIK-2, mTRESK) or unaffected (TASK-1, THIK-1,
hTRESK) by this metal ion. The strong inhibition of IRIL by flu-
Figure 6. mSCG neurons express the three protein subunits of the TREK subfamily. A–C,
Specific FITC-conjugated antibodies against TREK-1 (A), TREK-2 (B), and TRAAK (C) stained
culturedmSCGneurons (green, left panels). DAPI-stainednuclei (blue) not surroundedbygreen
stain belong to satellite cells that often accompanied the neurons in the culture. Satellite cells
wereneverpositive for FITC, and they canbeobservedunderNomarski optics in the rightpanels.
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oxetine also suggests a minor contribution of TRAAK, since it is
considerably less sensitive to this drug than TREK-1 (Heurteaux
et al., 2006), and TREK-2 inhibition by fluoxetine has also been
reported (Kang et al., 2008). TRAAK homodimers have been
reported to be strongly blocked by ruthenium red, whereas
TREK-1was practically insensitive (Czirja´k and Enyedi, 2002); in
mSCG neurones IRIL was unaffected by 10 M RR (supplemental
Fig. 2, available at www.jneurosci.org as supplemental material).
Finally, intracellular acidification induced by extracellular appli-
cation of bicarbonate (Maingret et al., 1999b) provoked a dra-
matic outward current in mSCG neurons that was strongly
blocked by fluoxetine. As both TREK-1 and TREK-2 are strongly
activated by internal acidification, whereas TRAAK channels are
activated by internal alkalinization (Han et al., 2003), this result
indicates a poor functional expression of intracellularly alkaline-
activated channels when compared with acid-activated channels
in mSCG. It is generally accepted that DNP is a strong intracel-
lular acidic stimulus, and hence it should enhance TREK-1 and
TREK-2 channels. However, DNP induced an inward instead of
the expected outward current and it did not affect the IRIL at all.
Interestingly, a similar DNP-induced inward current (by inhibi-
tion of a putative background outward current) has been
reported in rat carotid body type I cells (Buckler and Vaughan-
Jones, 1998), which was associated with a very small fall in pHi
(maximum decrease, 0.09; DNP, 250 M), indicating that acidi-
fication was almost negligible and not responsible for the effects
of DNP. It is tempting to speculate that, in contrast to COS cells
(Duprat et al., 2000), DNP may not acidify SCG neurons.
It is far more complex to discriminate the contribution of
TREK-1 and/or TREK-2 to IRIL. Homomers of these two chan-
nels have a very similar pharmacological profile, and in mSCG
neurons, PCR and immunocytochemistry techniques are unin-
formative since they demonstrate that both subunits are ex-
pressed. The fact that IRIL was unaffected
by quinine could indicate a major contri-
bution of TREK-1 as quininewas reported
to have no effect on TREK-1 (Fink et al.,
1996) and TRAAK channels (Ozaita and
Vega-Saenz deMiera, 2002), while strongly
reduced putative TREK-2 currents (Kuch-
eryavykh et al., 2009). However, the true ef-
fect of quinine and quinidine on TREK
channels is rather uncertain as they have
been reported to inhibit TREK-1 (Patel et
al., 1998;Meadows et al., 2000) andTREK-2
(Lesage et al., 2000b; Kucheryavykh et al.,
2009), as well as to have no effect on both
these channels (Fink et al., 1996; Bang et al.,
2000; Han et al., 2002).
Cell-attached patches unequivocally
demonstrated the relatively profuse ex-
pression of TREK-2 channels in themem-
brane of mSCG neurons. In addition, a
second less frequent TREK-like channel
emerged with single-channel proper-
ties intermediate to those reported for
TREK-1 and TREK-2. TREK-like chan-
nels have a very noisy open state and the
bursting behavior characteristic of TREK
channels. The conductance of this chan-
nel is lower than that of TREK-2 at nega-
tive potentials but slightly higher at
positive potentials, such that they showed
weaker inward rectification. These characteristics and the value
of the conductance itself are nearly identical with those reported
for a TREK-like channel (termed AA3) in supraoptic neurons
(Han et al., 2003). The AA3 channel has been proposed to be a
novel member of the TREK subfamily because cotransfection of
all combinations of the three identified members of the TREK
subfamily failed to produce a channel with the same characteris-
tics. The absence of TRAAK channels in the membrane of mSCG
neurons was expected fromour general data, althoughwhy chan-
nels with characteristics similar to those reported for TREK-1 are
not evident is unclear.
Physiological role of TREK channels in sympathetic neurons
The isolated riluzole-activated current shown here displayed a
strong outward rectification at physiological potassium concen-
trations. This is consistent with the fact that activation of heter-
ologously expressed TREK-1 (Duprat et al., 2000), TREK-2
(Lesage et al., 2000b), andTRAAK (Fink et al., 1998;Duprat et al.,
2000) channels by riluzole mainly takes place in the outward but
not the inward direction. In fact, whole-cell, outwardly rectifying
I–V relationships with almost no inward current are typical of
heterologously expressed TREK-1 (Fink et al., 1996; Maingret et
al., 2000a; Kennard et al., 2005), TREK-2 (Bang et al., 2000;
Lesage et al., 2000b), and TRAAK (Fink et al., 1998; Lesage et al.,
2000a; Meadows et al., 2001) channels in physiological extracel-
lular K concentrations. The small true leakage current at the
resting membrane potential and the relatively positive resting
membrane potential previously reported in SCG cells (Lamas et
al., 2002, 2009) are also in agreement with the low open proba-
bility of TREK channels at room temperature and negative volt-
ages (Lesage et al., 2000b). As hypothesized for other currents,
K2P channels could stabilize rather than settle the resting mem-
brane potential, thereby maintaining the negative resting poten-
Figure 7. Large-conductance TREK-2 potassium channels were recorded in most cell-attached patches. Aa, TREK-2 cell-
attached single channel currents recorded at60, 0, and60mV in symmetrical 150 KCl solutions.Ab, Mean (SEM) current–
voltage relationships for 12TREK-2 channels showingdistinctive inward rectification.Ba, TREK-like single channel activity at60,
0, and60 mV in symmetrical solutions. Note the flickering and bursting behavior characteristic of TREK channels. Bb, Mean
(SEM) current–voltage relationships for three TREK-like channels showing weaker inward rectification. C, Closed; O, open.
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tial with a very low conductance. This hypothesis is attractive
from the energy saving point of view, and it would also allow
neurotransmitters and other physical and chemical stimuli, in the
case of TREK channels, to exert a fine modulation of this poten-
tial. This is also in agreement with the hypothesis that TREK-1
channel overexpression has a modest effect on input resistance;
nevertheless, it can still modulate the restingmembrane potential
in cultured hippocampal neurons (Yang and Jan, 2008).
Although essentially voltage independent, the characteristic
open rectification of TREK channels gives them a macro-
scopic I–V relationship functionally similar to that of voltage-
dependent potassium M-channels. Although mechanistically
different, at physiological K concentrations, TREK currents will
exert their influence at voltages similar to those in which the
voltage-dependent M-current activates (positive to approxi-
mately60mV).Hence, they could not only contribute to set the
resting membrane potential by stabilization but also to act as a
“brake” on action potential firing and to contribute to adapta-
tion in SCG neurons, as comprehensively demonstrated for
M-channels (Brown and Constanti, 1980; Lamas, 1998; Lamas et
al., 2002). This could explain the strong reduction in spike fre-
quency adaptation induced by barium (which inhibits both
KCNQ and TREK channels) in mSCG neurons when compared
with other more specific M-current inhibitors (Romero et al.,
2004). Our results using low concentrations of fluoxetine suggest
that, although adaptation is mainly under M-current control,
TREK channels induce a delay in the latency of the first action
potential evoked by depolarizing stimuli. To know whether
TREK channels have a more important role on the adaptation
than that showed here requires the discovery of a TREK-2 selec-
tive blocker. Even so, our results are congruent with TREK chan-
nels being already open and M-currents opening with a rather
slow time constant on depolarization.
Finally, the modulation of the M-current by muscarinic ago-
nists in sympathetic SCG neurons has been thoroughly studied,
and it is generally accepted that the depletion of PIP2 (phospha-
tidylinositol 4,5-bisphosphate) accounts for the M-current inhi-
bition (Suh and Hille, 2002; Winks et al., 2005). Recently,
muscarinic inhibition of TREK-2 channels was reported in a het-
erologous system (Kang et al., 2006), and it is tempting to spec-
ulate that the increase in excitability provoked by muscarinic
agonists inmSCG neuronsmay, at least in part, be attributable to
this inhibition. Whether, and to what extent, the modulation of
K2P channels plays a role on the synaptic performance of the
sympathetic ganglia deserves to be investigated.
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